The Benefits of Young Blood Transfusions for Alzheimer's Disease

A recent study concluded in November of 2017, it was done at the Stanford University School of Medicine. It was a clinical trial looking at the safety, tolerability, and feasibility of administering blood plasma from young donors to participants with mild to moderate Alzheimer's disease. Again, very similar thing that we're trying to treat here with young blood,. different study, which is a good thing because now you've got with multiple studies, if you're getting the same results, then you're getting closer to actually doing what a scientific experiment is supposed to do.